Page 438 - 16Neonatal Jaundice_compressed

Neonatal jaundice

Bibliographic Study Type & Number of Intervention & Comparison Dichotomous outcomes Continuous Outcomes
Information Evidence Level Patients/Characteristics (E:C) (Mean:SD: N)
2 - Gender (M/F):Not reported
Mean GA: Not reported
Mean BW: Not reported
Mean age at entry to study: Not
reported
Mean TSB: Not reported
Author: Methodology: N: Collected information included, Received Mean melanocytic coun (nevus ≥ 2mm):
Matichard E Case control study 58 Phototype (Fitzpatrick’s classification), phototherapy = 18 Phototherapy 3.5 ± 3.05
Behaviour in the sun,
Year: Blinding: Inclusion: Sun protection policy, Controls = 40 Controls:1.45 ± 1.99
2006 Not reported Primary school children (age 8 – History of phototherapy for neonatal
9) jaundice
Country: Randomisation:
France Not reported Exclusion: A melanocytic nevus count was
Not reported conducted by a dermatologistpy
182
ID: Evidence level:
2 - Demographics: The size of nevi was recorded < 2mm,
Gender (M/F) 30/28 2–5mm, > 5mm
Mean GA: N/A
Mean BW: NA
Mean age at entry to study: N/A
Mean TSB: N/A
Author: Methodology: N: No significant correlation found between heart rate, systolic
Turan O RCT 98 blood pressure, diastolic blood pressure and mean blood
pressure and serum nitric oxide and vascular endothelial growth
Year: Blinding: Inclusion: factor.
2004 Not reported Term and preterm babies
receiving phototherapy for
Country: Randomisation: hyperbilirubinaemia
Turkey Not reported
Exclusion:
183
ID: Evidence level: Congenital malformations,
1 - Sepsis, babies receiving positive
inotropic drugs

Demographics:
Gender (M/F):Not reported
Mean GA: 36.7 ± 3.2 weeks
Mean BW: 2880 ± 803 g
Mean age at entry to study: Not
reported
Mean TSB: Not reported
Author: Methodology: Review of in vivo studies of
Speck W Review effects of phototherapy on cell
DNA
Year: Blinding:
1979 Not reported

292